AmbioPharm: difference between revisions
Diff·revision 22 → 23·12:49, 25 Feb 2026
Difference between revision 22 and revision 23 of AmbioPharm. 4 lines changed; the page grew by 433 bytes.
| Revision 22 — 00:58, 17 Feb 2026 SerialCommaSeb (talk) add the research-use-only statement to the lead rather than only the footer 14,619 bytes ±0 | Revision 23 — 12:49, 25 Feb 2026 ListMakerLumi (talk) label the reception tally as weak, self-selected evidence at this point of use 15,052 bytes +433 | ||
|---|---|---|---|
| 85 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | 85 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} |
| 86 | 86 | ||
| + | 87 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} | |
| + | 88 | ||
| 87 | == Regulatory position and legal status == | 89 | == Regulatory position and legal status == |
| 88 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | 90 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} |
| 89 | 91 | ||
| 90 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | 92 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} |
| + | 93 | ||
| + | 94 | Import of such material for personal use is unlawful or restricted in many jurisdictions, and [[Customs seizure|seizure]] is a documented outcome. PeptidePedia describes the legal position and does not advise on it.{{r|ruo}} | |
| 91 | 95 | ||
| 92 | == References == | 96 | == References == |